COVID-19 Antibodies            – R&D Samples Available

At HyTest, we manufacture monoclonal antibodies and antigens that are mainly used as key components of laboratory tests. Our company is one of the most important raw material suppliers for the IVD industry.

Click here and order your COVID-19 Antibodies

Main product areas

Cardiac markers

Cardiac biomarkers for immunoassay development

Learn more

Metabolic syndrome

Immunological reagents for quantative immunoassays

Learn more

Veterinary diagnostics

Monoclonal antibodies and antigens for veterinary diagnostics

Learn more

Infectious diseases

Immunological reagents for infectious disease diagnostics

Learn more

Inflammation

Inflammation reagents for inflammation diagnostics

Learn more

What’s new?

Our newest updates and other important stories

New! COVID-19 Antibodies – R&D Samples Available

We are pleased to let you know that we are developing several monoclonal antibodies specific to SARS-CoV2...
Read more >>

New! HyTest Live Webinar - Diagnostics of COVID-19: Achievements, Challenges and Perspectives

Welcome to our next live Webinar!

Sign up now >>

COVID-19 Webpage

We want to support your assay development projects in this difficult time and combined all our COVID-19 related info and SARS CoV-2 related products together. Read more >>

COVID-19 Related Markers: MAbs for Etiological and Serological Examination

We offer following MAbs:
Anti-IgG, in vitro, antibody
Anti-IgM, in vitro, antibody
Anti-IgA, in vitro, antibody
Read more >>

COVID-19: Biomarkers to Distinguish Severity and Prognosis

Welcome to join our first live Webinar.

Read more and sign up today >>

Impact of COVID-19 on HyTest’s Operations

WHO declared the Coronavirus outbreak a pandemic in March, and we are very closely following the changing situation on a daily basis.
Read more >>

Product Catalog 2020 Published

Catalog includes our whole product range and also a list of selected articles published by HyTest scientists. See Catalog >>

We are Sponsoring Cancer Challenge

Cancer is the second most common cause of death in the world, and most common by 2030. This is why EU challenges cancer on a whole new level in 2020. Read more >>

New Products: NGAL Antibodies and Antigen

NGAL is a small glycoprotein found in blood and urine. It is expressed by kidney tubular cells after kidney injury and it has been indicated as a promising biomarker of acute kidney injury. Read more >>

New Team Member

We are delighted to introduce our latest team member, Juhana Rauramo. With effect from September 2019, Juhana has been the Chief Commercial Officer of HyTest. Read more >>

See AACC 2019 Workshop Video

Workshop session focused on HyTest’s 25 year history in studying cardiac markers and developing diagnostic tools in this area. See now >>


Dr. Saara Wittfooth is the winner of the second EFLM-HyTest Cardiac Marker Award. 

Find out how she sees cardiac disease diagnostics now and in the future. Read more >>

Products

Our product categories and clinical areas

What’s the latest?

Our news and articles

See more

Sign up to our newsletter

And be informed about new products and scientific findings

Thank you for your subscription!